Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Washington Legal Foundation: New Developments and Notable Trends for Drugs and Medical Devices

Summary

Related Content

EMTALA, Abortion Restrictions, and Potential Increased Enforcement: What Hospital Counsel Need to Know Now

Supreme Court Declines to Review $220 Million Drug Pricing Judgment Against Eli Lilly

Supreme Court Stays Fifth Circuit Order Banning Telehealth Prescribing and Mail Dispensing of Mifepristone

Major U.S. Supreme Court and Appellate Cases Decided in 2025

What the Supreme Court’s Tariff Decision Means for Presidential Power

Supreme Court Strikes Down IEEPA Tariffs; Refund Process to Be Determined

The Supreme Court Considers Presidential Authority

Mayo Clinic Tax Win Poised to Help Groups With Complex Missions (Bloomberg Law)

Supreme Court 2026-2027 Term Preview: Key Cases and Emerging Issues to Watch

Goodwin Earns Record Number of Honors at 2026 LMG Life Sciences Americas Awards

Eight Goodwin Partners Recognized by Benchmark Litigation’s 40 and Under List 2026

Managing IP 2026 Recognizes Goodwin Practices and Lawyers for Excellence in Intellectual Property

Goodwin Secures Two Appellate Victories in High-Stakes Life Sciences Disputes

Federal Circuit Bar Association’s 2026 Bench & Bar Conference

Hikma v. Amarin: What the Supreme Court's Decision Means for Skinny Labeling and Induced Infringement

The Legal 500 US 2026 Recognizes 47 Goodwin Practices and 185 Lawyers

Life Sciences

Appellate and Supreme Court Litigation

Products Litigation & Counseling